Revive Therapeutics Ltd. (RVVTF) (RVV) (31R) has decided to extend its previous private placement offering, which initially consisted of up to 30,952,381 units priced at $0.021 per unit, with the potential to generate up to $650,000 in gross proceeds. The company successfully concluded the first phase of this offering in August 2025 by issuing 2,900,000 units, raising $60,900. With this success, Revive can now potentially secure an additional $589,000 through the remaining units available for purchase in this private placement opportunity.